Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Kahn Brothers Group, latest 13F

Pfizer

In Kahn Brothers Group's portfolio · Kahn Brothers Group

Ticker PFE

Still in the portfolio as of Q3 2026. Every quarter it shows up in a Kahn Brothers Group 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q3 2026 Reduce 13% 403,301 1.9% $28.52 $11.5M
Q2 2026 Reduce 4% 464,001 1.8% $24.08 $11.2M
Q1 2026 Reduce 12% 484,733 2.4% $28.08 $13.6M
Q4 2025 Reduce 22% 553,950 2.4% $24.90 $13.8M
Q3 2025 Reduce 3% 707,144 3.4% $25.48 $18.0M
Q2 2025 Reduce 1% 730,989 3.6% $24.24 $17.7M
Q1 2025 Reduce 3% 735,189 3.8% $25.34 $18.6M
Q4 2024 Reduce 24% 761,090 4.4% $26.53 $20.2M
Q3 2024 Reduce 1% 997,025 5.0% $28.94 $28.9M
Q2 2024 Reduce 2% 1,002,430 4.7% $27.98 $28.0M
Q1 2024 No change 1,022,719 4.2% $27.75 $28.4M
Q4 2023 Reduce 3% 1,025,681 4.7% $28.79 $29.5M
Q3 2023 Reduce 1% 1,055,759 5.5% $33.17 $35.0M
Q2 2023 Add 4% 1,066,091 5.7% $36.68 $39.1M
Q1 2023 Reduce 1% 1,029,662 6.0% $40.80 $42.0M
Q4 2022 No change 1,038,306 7.0% $51.24 $53.2M
Q3 2022 No change 1,042,353 7.1% $43,760.09 $45.61B
Q2 2022 Add 1% 1,047,499 7.4% $52,430.16 $54.92B
Q1 2022 Add 2% 1,041,982 6.8% $51,769.85 $53.94B
Q4 2021 Add 4% 1,017,928 8.3% $59,050.00 $60.11B
Q3 2021 Add 19% 980,988 5.9% $43,010.00 $42.19B
Q2 2021 Add 24% 824,504 4.6% $39,160.00 $32.29B
Q1 2021 Reduce 2% 662,287 3.7% $36,230.00 $23.99B
Q4 2020 Reduce 3% 674,718 4.3% $36,810.00 $24.84B
Q3 2020 Reduce 9% 692,544 4.8% $36,700.00 $25.42B
Q2 2020 Reduce 1% 764,516 4.2% $32,700.00 $25.00B
Q1 2020 Reduce 5% 770,316 4.6% $32,640.00 $25.14B
Q4 2019 No change 809,784 3.8% $39,180.00 $31.73B
Q3 2019 Add 1% 811,787 3.7% $35,930.00 $29.17B
Q2 2019 Add 51% 806,016 4.4% $43,320.00 $34.92B
Q1 2019 No change 533,589 3.5% $42,470.00 $22.66B
Q4 2018 Reduce 1% 534,409 4.2% $43,650.00 $23.33B
Q3 2018 Reduce 2% 537,309 3.6% $44,070.00 $23.68B
Q2 2018 Reduce 1% 546,967 3.2% $36,280.00 $19.84B
Q1 2018 Reduce 1% 549,944 3.1% $35,490.00 $19.52B
Q4 2017 Reduce 1% 554,606 3.2% $36,220.00 $20.09B
Q3 2017 Reduce 3% 557,495 3.0% $35,700.00 $19.90B
Q2 2017 Reduce 13% 577,616 3.0% $33,590.00 $19.40B
Q1 2017 Reduce 22% 667,633 3.9% $34,210.00 $22.84B
Q4 2016 Reduce 6% 860,290 4.7% $32,480.00 $27.94B
Q3 2016 Reduce 20% 919,757 5.6% $33,870.00 $31.15B
Q2 2016 Reduce 20% 1,156,866 7.9% $35,210.00 $40.73B
Q1 2016 Reduce 8% 1,442,543 8.0% $29,640.01 $42.76B
Q4 2015 Reduce 6% 1,569,873 9.1% $32,280.01 $50.68B
Q3 2015 Reduce 6% 1,671,039 9.7% $31,410.00 $52.49B
Q2 2015 Reduce 2% 1,774,875 10.0% $33,530.00 $59.51B
Q1 2015 Reduce 4% 1,811,016 10.6% $34,790.01 $63.01B
Q4 2014 Reduce 5% 1,883,217 10.1% $31,150.00 $58.66B
Q3 2014 Reduce 7% 1,985,161 9.5% $29,570.01 $58.70B
Q2 2014 Add 1% 2,124,489 9.0% $29,260.89 $62.16B
Q1 2014 Add 11% 2,112,819 9.7% $32,120.00 $67.86B
Q4 2013 Reduce 24% 1,899,759 10.0% $30,630.00 $58.19B
Q3 2013 Reduce 1% 2,508,002 10.5% $28,725.00 $72.04B
Q2 2013 First 13F 2,541,622 11.0% $28,010.00 $71.19B

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.